Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humiome® Post LB for Gastrointestinal Symptoms in Female Athletes
NCT07366931Phase 2Not yet recruiting
- Sponsor
- Liverpool John Moores University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Liverpool John Moores University. Primary endpoint: Gastrointestinal Symptom Rating Scale scores at 3 months. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07366931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07366931.